New study shows promise in reducing surgical risks associated with surgica...( CHICAGO (August 10 2007) Surgeons ma...)

New study shows promise in reducing surgical risks associated with surgical bleeding

CHICAGO (August 10, 2007) Surgeons may have a new patient safety tool to stop moderate surgical bleeding without some of the concerns associated with the current standard blood-clotting treatment. New research published in the August issue of the Journal of the American College of Surgeons shows that recombinant human thrombin (rhThrombin) reduces the risk of surgical complications associated with the use of plasma-derived bovine thrombin (bThrombin), which is currently the only commercially available stand-alone thrombin used to improve clotting during surgical procedures and stop bleeding.

Each year, bThrombin is used to treat more than one million patients who undergo surgical procedures in the United States. However, approximately 20 percent of these patients develop antibodies against bovine coagulation factors that can cross-react with human coagulation proteins and possibly lead to adverse effects, including severe bleeding and thrombosis. Due to these safety concerns, rhThrombin was developed as an alternative to bThrombin.

We constantly look for new ways to reduce risks in surgery and stopping surgical bleeding safely and effectively is of foremost interest to surgeons. The results from this phase III trial show that we can stop bleeding in 95 percent of patients within 10 minutes and do so without introducing foreign proteins that can carry greater risk of development of antibodies, said William C. Chapman, MD, FACS, Department of Surgery, Washington University, St. Louis (MO) School of Medicine. Im most encouraged by the increasing evidence that recombinant technology is safe and effective because it means that we may be able to avoid using blood or blood products from other people or animals and automatically diminish the risk of infection and the associated immunologic responses that have been noted in the past.

The randomized, double-blind comparative study included 411 patients who underwent surgical procedures at
'"/>

Contact: Sally Garneski
pressinquiry@facs.org
312-202-5409
Weber Shandwick Worldwide
10-Aug-2007

Page: 1 2
Related medicine news :

1. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
2. Penn study finds pro-death proteins required to regulate healthy immune function
3. New study counts the economic cost of persistent pain in Australia
4. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
5. Most seniors now have drug coverage, U-M study shows
6. To gain muscle and lose fat, drink milk: study
7. Wheres the beef? Not enough of it is on elders plates, muscle-metabolism study suggests
8. Even older women at high risk have little interest in being tested for HIV, study finds
9. Metabolic study in mice could lead to good cholesterol boosters
10. Michigan-CDC study supports value of social restrictions during influenza pandemics
11. Old McDonalds has a hold on kids taste buds, Stanford/Packard study finds

Post Your Comments: